BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16124128)

  • 1. Kaposi's sarcoma after renal transplantation.
    Gutiérrez-Dalmau A; Campistol JM
    N Engl J Med; 2005 Aug; 353(8):846-7; author reply 846-7. PubMed ID: 16124128
    [No Abstract]   [Full Text] [Related]  

  • 2. Sirolimus to replace calcineurin inhibitors? Too early yet.
    Cravedi P; Ruggenenti P; Remuzzi G
    Lancet; 2009 Apr; 373(9671):1235-6. PubMed ID: 19362662
    [No Abstract]   [Full Text] [Related]  

  • 3. No recurrence of Kaposi's sarcoma in a case of renal retransplantation under a calcineurin inhibitor free immunosuppressive regimen: first report.
    Segoloni GP; Giraudi R; Messina M; Rossetti M; Biancone L; Leonardi G; Piccoli GB; Magnano A; Gai M
    Transpl Int; 2007 Apr; 20(4):395-6. PubMed ID: 17326783
    [No Abstract]   [Full Text] [Related]  

  • 4. Sirolimus for Kaposi's sarcoma in renal-transplant recipients.
    Stallone G; Schena A; Infante B; Di Paolo S; Loverre A; Maggio G; Ranieri E; Gesualdo L; Schena FP; Grandaliano G
    N Engl J Med; 2005 Mar; 352(13):1317-23. PubMed ID: 15800227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.
    Yilmaz R; Akoglu H; Kirkpantur A; Kilickap S; Arici M; Altun B; Aki T; Erdem Y; Yasavul U; Turgan C
    Ren Fail; 2007; 29(1):103-5. PubMed ID: 17365918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of post-transplant Kaposi's sarcoma using sirolimus.
    Kolhe N; Mamode N; Van der Walt J; Pattison J
    Int J Clin Pract; 2006 Nov; 60(11):1509-12. PubMed ID: 16787440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi's sarcoma after renal transplantation.
    Kanitakis J
    N Engl J Med; 2005 Aug; 353(8):846-7; author reply 846-7. PubMed ID: 16120869
    [No Abstract]   [Full Text] [Related]  

  • 8. Kaposi's sarcoma after renal transplantation--disappearance after reduction of immunosuppression and reappearance 7 years later after start of mycophenolate mofetil treatment.
    Gómez E; Aguado S; Rodríguez M; Alvarez-Grande J
    Nephrol Dial Transplant; 1998 Dec; 13(12):3279-80. PubMed ID: 9870518
    [No Abstract]   [Full Text] [Related]  

  • 9. Reccurence of Kaposi's sarcoma after increased exposure to sirolimus.
    Boratyńska M; Zmonarski SC; Klinger M
    Int Immunopharmacol; 2006 Dec; 6(13-14):2018-22. PubMed ID: 17161356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leflunomide with low-dose everolimus for treatment of Kaposi's sarcoma in a renal allograft recipient.
    Basu G; Mohapatra A; Manipadam MT; Mani SE; John GT
    Nephrol Dial Transplant; 2011 Oct; 26(10):3412-5. PubMed ID: 21775763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus and regression of Kaposi's sarcoma in immunosuppressed transplant patient.
    Pranteda G; Feliziani G; Grimaldi M; Paleologo G; Pranteda G; Melotti F; Camplone G
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1022-3. PubMed ID: 18194240
    [No Abstract]   [Full Text] [Related]  

  • 12. Regression of post-transplant Kaposi sarcoma after discontinuing cyclosporin and giving mycophenolate mofetil instead.
    Hussein MM; Mooij JM; Roujouleh HM
    Nephrol Dial Transplant; 2000 Jul; 15(7):1103-4. PubMed ID: 10862670
    [No Abstract]   [Full Text] [Related]  

  • 13. Kaposi's sarcoma in the early post-transplant period in a kidney transplant recipient.
    Ercan Z; Demir ME; Merhametsiz O; Yayar O; Ulas T; Ayli MD
    Nefrologia; 2013 Nov; 33(6):861-2. PubMed ID: 24241380
    [No Abstract]   [Full Text] [Related]  

  • 14. Complete regression of visceral Kaposi's sarcoma after conversion to sirolimus.
    Mohsin N; Budruddin M; Pakkyara A; Darweesh A; Nayyer M; Amitabh J; Daar AS
    Exp Clin Transplant; 2005 Dec; 3(2):366-9. PubMed ID: 16417445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus for visceral and cutaneous Kaposi's sarcoma in a renal-transplant recipient.
    Gheith O; Bakr A; Wafa E; Fouda A; El Agroudy A; Refaie A; Donia A; Sabry A; Sobh M; Shokeir A; Ghoneim M
    Clin Exp Nephrol; 2007 Sep; 11(3):251-254. PubMed ID: 17891357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of Kaposi's sarcoma in renal graft recipients after conversion to sirolimus treatment.
    Zmonarski SC; Boratyńska M; Rabczyński J; Kazimierczak K; Klinger M
    Transplant Proc; 2005 Mar; 37(2):964-6. PubMed ID: 15848592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
    Volkow P; Zinser JW; Correa-Rotter R
    BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus for Kaposi's sarcoma.
    Wasywich CA; Croxson MC; van Doornum GJ; Coverdale HA; Ruygrok PN
    J Heart Lung Transplant; 2006 Jun; 25(6):726-9. PubMed ID: 16730579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin for Kaposi's sarcoma and graft-versus-host disease in bone marrow transplant recipient.
    Marco de F; Infante B; Giovanni S; Gesualdo L
    Transplantation; 2010 Mar; 89(5):633-4. PubMed ID: 20216371
    [No Abstract]   [Full Text] [Related]  

  • 20. Sirolimus conversion for patients with posttransplant Kaposi's sarcoma.
    Lebbé C; Euvrard S; Barrou B; Pouteil-Noble C; Garnier JL; Glotz D; Legendre C; Francès C
    Am J Transplant; 2006 Sep; 6(9):2164-8. PubMed ID: 16780549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.